The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor α-mediated rat hepatocyte survival and apoptosis
Open Access
- 1 February 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (2) , 420-427
- https://doi.org/10.1002/hep.510310223
Abstract
Perturbation of hepatocyte growth regulation is associated with a number of liver diseases such as fibrosis and cancer. These diseases are mediated by a network of growth factors and cytokines that regulate the induction of hepatocyte proliferation and apoptosis. In this study, we have investigated the role of signaling pathways activated by tumor necrosis factor α (TNF-α) and epidermal growth factor (EGF) in the regulation of apoptosis induced by transforming growth factor β1 (TGF-β1), because this physiological factor is believed to regulate spontaneous apoptosis in the liver. We show that pretreatment with (10 ng/mL) EGF or (25 ng/mL) TNF-α can suppress TGF-β1-induced apoptosis by 73% and 50%, respectively, in isolated rat hepatocytes. However, suppression of TGF-β1-induced apoptosis by EGF and TNF-α occurs via different protein kinase signaling pathways. Using specific inhibitors, we show that suppression of apoptosis by EGF is dependent on activation of phosphoinositide 3-kinase (PI 3-kinase) and the extracellular signal regulated kinase (ERK) mitogen-activated protein (MAP) kinase pathways, but not p38 MAP kinase. In contrast, suppression of TGF-β1-induced apoptosis by TNF-α does not require PI 3-kinase and protein kinase B (PKB or Akt)-mediated pathways, but is dependent on ERK and p38 MAP kinase activity. These data contribute to our understanding of the intracellular survival signals that play a role in normal liver homeostasis and in diverse pathological conditions.Keywords
This publication has 60 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Cytokines in non-genotoxic hepatocarcinogenesisCarcinogenesis: Integrative Cancer Research, 1999
- Inhibition of Rat Hepatocyte Proliferation by Transforming Growth Factor β and Glucagon Is Associated With Inhibition of Erk2 and P70 S6 KinaseHepatology, 1999
- Hepatocyte apoptosis and hepatic expression of transforming growth factor-β1mRNA during involution of hyperplastic rat liver induced by hepatocyte growth factorJournal of Gastroenterology and Hepatology, 1998
- Delayed fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNFαHepatology, 1998
- Response to transforming growth factor α (TGFα) and epidermal growth factor (EGF) in hepatocytes: Lower EGF receptor affinity of TGFα is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesisJournal of Cellular Physiology, 1998
- Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinaseFEBS Letters, 1996
- Reduced expression of mature TGFβ1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopinMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996
- Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor-beta in fetal hepatocytes in primary cultureFEBS Letters, 1996
- Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosisCarcinogenesis: Integrative Cancer Research, 1996